COVID Treatment Quick Start Consortium Press Room

About

The COVID Treatment Quick Start Consortium will support governments to introduce and scale up access to new and effective COVID-19 oral antiviral therapies in high-risk populations. Partner countries include Ghana, Kenya, Laos, Malawi, Nigeria, Rwanda, South Africa, Uganda, Zambia, and Zimbabwe.  The Consortium brings together Duke University, the Clinton Health Access Initiative (CHAI), COVID Collaborative, and Americares as implementing partners, with support from the Open Society Foundations, Pfizer and the Conrad N. Hilton Foundation.

To learn more: 

Embargoed Press Release

Media Advisory     

Speaker Bios

Dr. Krishna Udayakumar, Founding Director of the Duke Global Health Innovation Center

Mr. Gary Edson, President of the COVID Collaborative 

Mr. Sean Regan, Director COVID Treatment Access, Clinton Health Access Initiative (CHAI) 

Dr. Neil Buddy Shah, Chief Executive Officer of CHAI

Christine Squires, President and CEO of Americares

Prof Claude Muvunyi, Director General, Rwanda Biomedical Center

Prof Lloyd B.  Mulenga, Director of Infectious Diseases for the Ministry of Health, Zambia  

Caroline Roan, Senior Vice President, Global Health & Social Impact, and Chief Sustainability Officer for Pfizer

Mark Malloch-Brown, President of the Open Society Foundations

Peter Laugharn, President & CEO of the Conrad N. Hilton Foundation

Quotes